We have consolidated our leadership in the therapy areas where we provide healthcare solutions to patients, with a wide range of prescription medicines across therapy areas covering immuno-inflammation, respiratory, dermatology, nutrition, gastrointestinal and rare diseases.
Our leading pharmaceuticals brands
14 GSK brands feature in the top 300 brands, of which the following pharmaceuticals brands feature: Augmentin, Calpol, Zinetac, Betnovate-N, Betnovate-C, Eltroxin, Ceftum, Betnesol, T-Bact, Phexin and CCM.
In a vast global market for pharmaceuticals, the Asia Pacific region has seen the biggest growth over recent years and the Indian pharmaceuticals market is spearheading this growth. This trend is expected to continue as the world’s population grows, economies in the emerging markets become more prosperous and global changes in lifestyles affect long-term health.
Demand for quality healthcare has also been driven by the growing health insurance sector, which has in turn strengthened demand for quality in healthcare solutions.
With opportunities in India opening up, GSK India is aligning itself with the parent company in areas such as clinical trials, clinical data management, global pack management, sourcing raw material and support for business processes including analytics.